Twin Peaks Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44	Closed	-$636	–	946
2026 Q1	$636	Buy	+44	New	+$631	﹤0.01%	1992

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Twin Peaks Wealth Advisors's FOLD Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 44 shares — an estimated $636 sold.

Twin Peaks Wealth Advisors first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $636 in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Twin Peaks Wealth Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Twin Peaks Wealth Advisors sold 44 Amicus Therapeutics shares in Q2 2026, an estimated $636.
Twin Peaks Wealth Advisors first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Twin Peaks Wealth Advisors's Amicus Therapeutics position peaked at $636 in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.